IHP 610 Module 7 Health Law Paper Example

Buying the Rival Across Town: Antitrust Risk and Evidence for Prairie Ridge Health

[Student Name]

Southern New Hampshire University

IHP 610: Health Policy and Law

Module Seven Paper

[Instructor Name]

[Date]

The organization, setting and figures below are a composite written as a model document. No real employer, client, colleague or patient is described.

Buying the Rival Across Town: Antitrust Risk and Evidence for Prairie Ridge Health

Crossroads Medical Center, a 180-bed independent hospital six miles from Prairie Ridge Health's flagship, has approached Prairie Ridge about a sale. Crossroads has lost money for three years and fears closure. Some Prairie Ridge trustees see a chance to strengthen the system and protect local jobs. This paper examines the legal framework that governs hospital mergers, reviews evidence on how consolidation affects prices and quality and assesses whether the acquisition is advisable.

The Market Today

The county has three general acute care hospitals. Prairie Ridge's flagship has about 48% of inpatient admissions, Crossroads about 20% and a third hospital, 22 miles away, about 32%. After the acquisition, Prairie Ridge would control about 68% of admissions and every hospital within a fifteen-minute drive for most county residents. Commercial insurers would have little choice but to include the combined system in their networks.

The Federal Antitrust Framework

Three federal laws matter most. Section 1 of the Sherman Act prohibits agreements that unreasonably restrain trade, such as price fixing between competitors. Section 2 prohibits monopolization and attempts to monopolize. Section 7 of the Clayton Act prohibits mergers and acquisitions whose effect may be substantially to lessen competition or tend to create a monopoly, which is the main standard for hospital deals. Under the Hart-Scott-Rodino Act, transactions above a size threshold must be reported in advance to both federal enforcers, the FTC and the Justice Department's Antitrust Division, before closing, giving the agencies time to investigate and, if they choose, to sue to block the deal.

How Agencies Judge Hospital Mergers

The agencies define a relevant market by service and geography, often asking where commercially insured patients would go if prices rose, and measure concentration with the Herfindahl-Hirschman Index, which squares each competitor's percentage share and adds the results. A merger that sharply raises an already high index is presumed likely to harm competition. The Commission has challenged many hospital mergers over the past two decades and won several in court, and hospitals claiming the deal will produce efficiencies or save a failing hospital bear a heavy burden to prove it.

Applying the Test

Using admission shares, the county's index is about 2,200 today: 48 squared plus 20 squared plus 32 squared. After the acquisition, it would be about 3,400: 68 squared plus 32 squared. A post-merger index above 1,800 combined with an increase of well over 100 points is presumed to enhance market power under current federal merger guidelines. By that measure, the deal would draw close scrutiny and a substantial risk of challenge.

Table 1. Market Concentration Before and After the Proposed Acquisition

Note. Composite admission shares; HHI rounded.

What Happens to Prices

Cooper et al. (2019) used claims data from large commercial insurers covering tens of millions of people and found wide variation in hospital prices across and within markets. Hospitals facing no nearby competitor charged substantially more than those in markets with several rivals, and mergers between hospitals located close to each other were followed by significant price increases, while mergers between distant hospitals were not. For a deal between hospitals six miles apart, the evidence points toward higher commercial prices.

The Broader Evidence

Gaynor et al. (2015) reviewed the economics of health care markets and concluded that hospital consolidation in concentrated markets generally leads to higher prices for private insurers, with little evidence that the savings claimed by merging parties are passed on. They also found that competition, particularly under regulated prices such as Medicare's, tends to improve quality, whereas the effects of consolidation on quality were mixed and sometimes negative.

Does Quality Improve After Acquisition?

Merging parties often promise better quality. Beaulieu et al. (2020) compared hospitals acquired between 2009 and 2013 with similar hospitals that were not acquired. They found modest declines in patient experience scores after acquisition and no significant improvements in readmissions or mortality, suggesting that quality gains claimed for mergers did not, on average, materialize.

State Law Options

Some states allow hospitals to seek a certificate of public advantage, which replaces federal antitrust review with state supervision in exchange for commitments on prices, quality and access. Prairie Ridge's state enacted such a law in 2019. Critics note that state oversight can weaken over time and that price commitments often expire; the Federal Trade Commission has publicly opposed several such arrangements. Pursuing one would also bring years of reporting obligations and public attention.

The Failing Hospital Argument

Prairie Ridge could argue that Crossroads would close without the deal. Courts accept a failing firm defense only in narrow circumstances: the hospital must face imminent failure, be unable to reorganize and have made good-faith efforts to find a less anticompetitive buyer. Crossroads has losses but has not sought other buyers, so the defense would likely fail today.

Alternatives to Acquisition

Prairie Ridge could pursue a clinical affiliation instead: shared cardiology and stroke services, joint purchasing, a common electronic record platform and transfer agreements, without combining ownership or joint price negotiation with insurers. Such arrangements must avoid sharing price information and coordinating contracts, which could violate section 1 of the Sherman Act, but they carry far less risk and could stabilize Crossroads financially.

Recommendation

Given a post-merger index near 3,400, strong evidence that nearby hospital mergers raise prices and weak evidence of quality gains, Prairie Ridge should not pursue the acquisition at this time. It should instead negotiate a clinical affiliation with Crossroads, with antitrust counsel reviewing every element, and encourage Crossroads to test the market for other partners. If Crossroads later meets the conditions of the failing firm defense, the board could revisit the question.

Conclusion

Antitrust law exists to protect patients and employers from the higher prices that concentrated hospital markets produce. The proposed acquisition would likely raise those prices, would face a serious federal challenge and would probably not improve quality. A carefully structured affiliation offers Prairie Ridge a way to support its neighbor without buying it.

References

Beaulieu, N. D., Dafny, L. S., Landon, B. E., Dalton, J. B., Kuye, I., & McWilliams, J. M. (2020). Changes in quality of care after hospital mergers and acquisitions. New England Journal of Medicine, 382(1), 51-59. https://doi.org/10.1056/NEJMsa1901383

Cooper, Z., Craig, S. V., Gaynor, M., & Van Reenen, J. (2019). The price ain't right? Hospital prices and health spending on the privately insured. The Quarterly Journal of Economics, 134(1), 51-107. https://doi.org/10.1093/qje/qjy020

Gaynor, M., Ho, K., & Town, R. J. (2015). The industrial organization of health-care markets. Journal of Economic Literature, 53(2), 235-284. https://doi.org/10.1257/jel.53.2.235